Highlights and Quick Summary
- Accounts Receivable Change for the quarter ending March 31, 2022 was $300 Million
- Annual Accounts Receivable Change for 2021 was $-300 Million
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Accounts Receivable Change of Beam Therapeutics Inc.
Most recent Accounts Receivable Changeof BEAM including historical data for past 10 years.Interactive Chart of Accounts Receivable Change of Beam Therapeutics Inc.
Beam Therapeutics Inc. Accounts Receivable Change for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | $300.0 | – |
| 2021 | – | – | – | – | $-300.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology